Skip to content

Humacyte, Inc.

HUMA HUMAW

CIK 0001818382

← back to feed
Revenue (TTM)
$2.07M
Q1 May 2026
Net Income (TTM)
−$33.65M
+72.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.16
+79.4% YoY Q1 May 2026
Gross Margin
-28.7%
Q1 May 2026
Operating Margin
-5,142.1%
Q1 May 2026
Net Margin
-1,628.7%
Q1 May 2026
Free Cash Flow (TTM)
−$101.64M
Q1 May 2026
Cash
$48.54M
Q1 May 2026
Total Debt
$35.87M
Q1 May 2026
Shares Outstanding
222.02M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings